Investigational Drug Information for Abediterol
✉ Email this page to a colleague
What is the drug development status for Abediterol?
Abediterol is an investigational drug.
There have been 4 clinical trials for Abediterol.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 28th 2020.
The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, and Lung Diseases. The leading clinical trial sponsors are AstraZeneca, Parexel, and [disabled in preview].
There are one hundred and thirty-one US patents protecting this investigational drug and one international patent.
Summary for Abediterol
| US Patents | 131 |
| International Patents | 1,979 |
| US Patent Applications | 293 |
| WIPO Patent Applications | 174 |
| Japanese Patent Applications | 63 |
| Clinical Trial Progress | Phase 1 (2020-01-28) |
| Vendors | 7 |
Recent Clinical Trials for Abediterol
| Title | Sponsor | Phase |
|---|---|---|
| Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers. | Parexel | Phase 1 |
| Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers. | AstraZeneca | Phase 1 |
| To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids | AstraZeneca | Phase 1 |
Clinical Trial Summary for Abediterol
Top disease conditions for Abediterol
Top clinical trial sponsors for Abediterol
US Patents for Abediterol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Abediterol | ⤷ Try a Trial | Compounds | CHIESI FARMACEUTICI S.P.A. (Parma, IT) | ⤷ Try a Trial |
| Abediterol | ⤷ Try a Trial | Dosage and formulation | Almirall, S.A. (Barcelona, ES) | ⤷ Try a Trial |
| Abediterol | ⤷ Try a Trial | 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors | Chiesi Farmaceutici S.p.A. (Parma, IT) | ⤷ Try a Trial |
| Abediterol | ⤷ Try a Trial | Aminoester derivatives | CHIESI FARMACEUTICI S.p.A. (Parma, IT) | ⤷ Try a Trial |
| Abediterol | ⤷ Try a Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try a Trial |
| Abediterol | ⤷ Try a Trial | Pyrazolyl-substituted heteroaryls and their use as medicaments | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Abediterol
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Abediterol | Argentina | AR108610 | 2036-05-31 | ⤷ Try a Trial |
| Abediterol | Australia | AU2017272405 | 2036-05-31 | ⤷ Try a Trial |
| Abediterol | Brazil | BR112018074608 | 2036-05-31 | ⤷ Try a Trial |
| Abediterol | Canada | CA3020435 | 2036-05-31 | ⤷ Try a Trial |
| Abediterol | Chile | CL2018003417 | 2036-05-31 | ⤷ Try a Trial |
| Abediterol | China | CN109311850 | 2036-05-31 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
